Log In
Print
BCIQ
Print
Print this Print this
 

sarilumab (REGN88, SAR153191)

  Manage Alerts
Collapse Summary General Information
Company Regeneron Pharmaceuticals Inc.
DescriptionHuman mAb against IL-6 receptor
Molecular Target Interleukin-6 (IL-6) receptor (CD126)
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase III
IndicationRheumatoid arthritis (RA)
Partner

Sanofi
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today